InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-15 · accession 0001055726-24-000029 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-16 2024-05-15 INO Sumner Michael John Chief Medical Off M - OptEx — +2,386 5,302 +82% —
D 2024-05-16 2024-05-15 INO Sumner Michael John Chief Medical Off M - OptEx $0.00 -2,386 4,770 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-15 M A 2,386 — 5,302 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units is as follows: 2,386 shares vested on May 15, 2024; 2,385 shares will vest on May 15, 2025; and 2,385 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
2 Derivative Restricted Stock Unit 2024-05-15 M D 2,386 $0.00 4,770 D — · — to — 2,386 Common Stock (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units is as follows: 2,386 shares vested on May 15, 2024; 2,385 shares will vest on May 15, 2025; and 2,385 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.